Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtrer
Plus de filtres











Gamme d'année
1.
Radiol Bras ; 56(1): 13-20, 2023.
Article de Anglais | MEDLINE | ID: mdl-36926359

RÉSUMÉ

Objective: To measure the potential radiation dose emitted by patients who have recently undergone diagnostic nuclear medicine procedures, in order to establish optimal radiation safety measures for such procedures. Materials and Methods: We evaluated the radiation doses emitted by 175 adult patients in whom technetium-99m, iodine-131, and fluorine-18 radionuclides were administered for bone, kidney, heart, brain, and whole-body scans, as measured with a radiation detector. Those values served as the basis for evaluating whole-body radiopharmaceutical clearance, as well as the risk for the exposure of others to radiation, depending on the time elapsed since administration of the radiopharmaceutical. Results: The mean time to clearance of the radiopharmaceuticals administered, expressed as the effective half-life, ranged from 1.18 ± 0.30 h to 11.41 ± 0.02 h, and the mean maximum cumulative radiation dose at 1.0 m from the patients was 149.74 ± 56.72 µSv. Even at a distance of 0.5 m, the cumulative dose was found to be only half and one tenth of the limits established for exposure of the general public and family members/caregivers (1.0 mSv and 5.0 mSv per episode, respectively). Conclusion: Cumulative radiation doses emitted by patients immediately after diagnostic nuclear medicine procedures are considerably lower than the limits established by the International Commission on Radiological Protection and the International Atomic Energy Agency, and precautionary measures to avoid radiation exposure are therefore not required after such procedures.


Objetivo: O objetivo deste trabalho foi levantar o potencial de dose de radiação emitida por pacientes em procedimentos diagnósticos, visando a estabelecer cuidados de radioproteção mais otimizados. Materiais e Métodos: Taxas de dose de radiação emitidas por 175 pacientes administrados com os radionuclídeos 99mTc, 131I e 18F para cintilografias óssea, renal, cardíaca, cerebral e corpo inteiro, foram mensuradas com um detector de radiação, servindo para avaliar o clareamento do radiofármaco no organismo e risco de exposição após administração dos radiofármacos. Resultados: O clareamento, representado pela meia-vida efetiva, variou de 1,18 ± 0,30 h até 11,41 ± 0,02 h e a dose de radiação máxima acumulada oferecida pelos pacientes a 1,0 m foi de 149,74 ± 56,72 µSv. Mesmo para distâncias de 0,5 m, as doses estimadas foram, respectivamente, duas e dez vezes inferiores ao nível de restrição para o público geral (1,0 mSv) e exposição médica (5,0 mSv/episódio). Conclusão: Doses de radiação oferecidas por pacientes em procedimentos diagnósticos são inferiores aos níveis de restrição recomendados pela International Commission on Radiological Protection e International Atomic Energy Agency, e assim, cuidados de radioproteção são geralmente desnecessários.

2.
Radiol. bras ; Radiol. bras;56(1): 13-20, Jan.-Feb. 2023. tab, graf
Article de Anglais | LILACS-Express | LILACS | ID: biblio-1422524

RÉSUMÉ

Abstract Objective: To measure the potential radiation dose emitted by patients who have recently undergone diagnostic nuclear medicine procedures, in order to establish optimal radiation safety measures for such procedures. Materials and Methods: We evaluated the radiation doses emitted by 175 adult patients in whom technetium-99m, iodine-131, and fluorine-18 radionuclides were administered for bone, kidney, heart, brain, and whole-body scans, as measured with a radiation detector. Those values served as the basis for evaluating whole-body radiopharmaceutical clearance, as well as the risk for the exposure of others to radiation, depending on the time elapsed since administration of the radiopharmaceutical. Results: The mean time to clearance of the radiopharmaceuticals administered, expressed as the effective half-life, ranged from 1.18 ± 0.30 h to 11.41 ± 0.02 h, and the mean maximum cumulative radiation dose at 1.0 m from the patients was 149.74 ± 56.72 µSv. Even at a distance of 0.5 m, the cumulative dose was found to be only half and one tenth of the limits established for exposure of the general public and family members/caregivers (1.0 mSv and 5.0 mSv per episode, respectively). Conclusion: Cumulative radiation doses emitted by patients immediately after diagnostic nuclear medicine procedures are considerably lower than the limits established by the International Commission on Radiological Protection and the International Atomic Energy Agency, and precautionary measures to avoid radiation exposure are therefore not required after such procedures.


Resumo Objetivo: O objetivo deste trabalho foi levantar o potencial de dose de radiação emitida por pacientes em procedimentos diagnósticos, visando a estabelecer cuidados de radioproteção mais otimizados. Materiais e Métodos: Taxas de dose de radiação emitidas por 175 pacientes administrados com os radionuclídeos 99mTc, 131I e 18F para cintilografias óssea, renal, cardíaca, cerebral e corpo inteiro, foram mensuradas com um detector de radiação, servindo para avaliar o clareamento do radiofármaco no organismo e risco de exposição após administração dos radiofármacos. Resultados: O clareamento, representado pela meia-vida efetiva, variou de 1,18 ± 0,30 h até 11,41 ± 0,02 h e a dose de radiação máxima acumulada oferecida pelos pacientes a 1,0 m foi de 149,74 ± 56,72 µSv. Mesmo para distâncias de 0,5 m, as doses estimadas foram, respectivamente, duas e dez vezes inferiores ao nível de restrição para o público geral (1,0 mSv) e exposição médica (5,0 mSv/episódio). Conclusão: Doses de radiação oferecidas por pacientes em procedimentos diagnósticos são inferiores aos níveis de restrição recomendados pela International Commission on Radiological Protection e International Atomic Energy Agency, e assim, cuidados de radioproteção são geralmente desnecessários.

3.
Radiol Bras ; 49(2): 92-7, 2016.
Article de Anglais | MEDLINE | ID: mdl-27141131

RÉSUMÉ

OBJECTIVE: To perform a comparative dosimetric analysis, based on computer simulations, of temporary balloon implants with (99m)Tc and balloon brachytherapy with high-dose-rate (HDR) (192)Ir, as boosts to radiotherapy. We hypothesized that the two techniques would produce equivalent doses under pre-established conditions of activity and exposure time. MATERIALS AND METHODS: Simulations of implants with (99m)Tc-filled and HDR (192)Ir-filled balloons were performed with the Siscodes/MCNP5, modeling in voxels a magnetic resonance imaging set related to a young female. Spatial dose rate distributions were determined. In the dosimetric analysis of the protocols, the exposure time and the level of activity required were specified. RESULTS: The (99m)Tc balloon presented a weighted dose rate in the tumor bed of 0.428 cGy.h(-1).mCi(-1) and 0.190 cGyh(-1).mCi(-1) at the balloon surface and at 8-10 mm from the surface, respectively, compared with 0.499 and 0.150 cGyh(-1).mCi(-1), respectively, for the HDR (192)Ir balloon. An exposure time of 24 hours was required for the (99m)Tc balloon to produce a boost of 10.14 Gy with 1.0 Ci, whereas only 24 minutes with 10.0 Ci segments were required for the HDR (192)Ir balloon to produce a boost of 5.14 Gy at the same reference point, or 10.28 Gy in two 24-minutes fractions. CONCLUSION: Temporary (99m)Tc balloon implantation is an attractive option for adjuvant radiotherapy in breast cancer, because of its availability, economic viability, and similar dosimetry in comparison with the use of HDR (192)Ir balloon implantation, which is the current standard in clinical practice.


OBJETIVO: Análise dosimétrica comparativa entre técnicas de implantes temporários de reforço por meio de balões de 99mTc e de 192Ir de alta taxa de dose (high dose rate - HDR) mediante simulação computacional. A hipótese é que ambos produzem dosimetria equivalente em condições pré-estabelecidas de atividade e exposição. MATERIAIS E MÉTODOS: Simulações de implantes com balão preenchido com 99mTc e balão HDR-192Ir foram elaboradas no Siscodes/ MCNP5, modelando em voxels um tórax feminino reproduzido de ressonância magnética de mama jovem. Distribuições espaciais de taxas de dose absorvidas foram geradas. Análises dosimétricas dos protocolos foram apresentadas especificando tempo acumulado e atividade requerida. RESULTADOS: Implante temporário com balão-99mTc apresentou taxa de dose ponderada no leito do tumor, na adjacência do balão, de 0,428 cGyh-1.mCi-1, e a 8-10 mm distante, de 0,190 cGyh-1.mCi-1, enquanto o implante de balão com 192Ir apresentou 0,499 e 0,150 cGyh-1.mCi-1, respectivamente. A exposição de 24 horas para balão-99mTc foi necessária para produzir o reforço de 10,14 Gy com 1,0 Ci, ao passo que para balão HDR-192Ir foram necessários 24 minutos com segmentos de 10,0 Ci para gerar 5,14 Gy no mesmo ponto de referência, ou 10,28 Gy em duas frações de 24 minutos. CONCLUSÃO: Implante temporário com balão-99mTc é atrativo para a radioterapia adjuvante do câncer de mama, devido a disponibilidade, viabilidade econômica e equivalência radiodosimétrica ao balão HDR-192Ir, protocolo presente na prática clínica.

4.
Radiol. bras ; Radiol. bras;49(2): 92-97, Mar.-Apr. 2016. tab, graf
Article de Anglais | LILACS | ID: lil-780922

RÉSUMÉ

Abstract Objective: To perform a comparative dosimetric analysis, based on computer simulations, of temporary balloon implants with 99mTc and balloon brachytherapy with high-dose-rate (HDR) 192Ir, as boosts to radiotherapy. We hypothesized that the two techniques would produce equivalent doses under pre-established conditions of activity and exposure time. Materials and Methods: Simulations of implants with 99mTc-filled and HDR 192Ir-filled balloons were performed with the Siscodes/MCNP5, modeling in voxels a magnetic resonance imaging set related to a young female. Spatial dose rate distributions were determined. In the dosimetric analysis of the protocols, the exposure time and the level of activity required were specified. Results: The 99mTc balloon presented a weighted dose rate in the tumor bed of 0.428 cGy.h-1.mCi-1 and 0.190 cGyh-1.mCi-1 at the balloon surface and at 8-10 mm from the surface, respectively, compared with 0.499 and 0.150 cGyh-1.mCi-1, respectively, for the HDR 192Ir balloon. An exposure time of 24 hours was required for the 99mTc balloon to produce a boost of 10.14 Gy with 1.0 Ci, whereas only 24 minutes with 10.0 Ci segments were required for the HDR 192Ir balloon to produce a boost of 5.14 Gy at the same reference point, or 10.28 Gy in two 24-minutes fractions. Conclusion: Temporary 99mTc balloon implantation is an attractive option for adjuvant radiotherapy in breast cancer, because of its availability, economic viability, and similar dosimetry in comparison with the use of HDR 192Ir balloon implantation, which is the current standard in clinical practice.


Resumo Objetivo: Análise dosimétrica comparativa entre técnicas de implantes temporários de reforço por meio de balões de 99mTc e de 192Ir de alta taxa de dose (high dose rate - HDR) mediante simulação computacional. A hipótese é que ambos produzem dosimetria equivalente em condições pré-estabelecidas de atividade e exposição. Materiais e Métodos: Simulações de implantes com balão preenchido com 99mTc e balão HDR-192Ir foram elaboradas no Siscodes/ MCNP5, modelando em voxels um tórax feminino reproduzido de ressonância magnética de mama jovem. Distribuições espaciais de taxas de dose absorvidas foram geradas. Análises dosimétricas dos protocolos foram apresentadas especificando tempo acumulado e atividade requerida. Resultados: Implante temporário com balão-99mTc apresentou taxa de dose ponderada no leito do tumor, na adjacência do balão, de 0,428 cGyh-1.mCi-1, e a 8-10 mm distante, de 0,190 cGyh-1.mCi-1, enquanto o implante de balão com 192Ir apresentou 0,499 e 0,150 cGyh-1.mCi-1, respectivamente. A exposição de 24 horas para balão-99mTc foi necessária para produzir o reforço de 10,14 Gy com 1,0 Ci, ao passo que para balão HDR-192Ir foram necessários 24 minutos com segmentos de 10,0 Ci para gerar 5,14 Gy no mesmo ponto de referência, ou 10,28 Gy em duas frações de 24 minutos. Conclusão: Implante temporário com balão-99mTc é atrativo para a radioterapia adjuvante do câncer de mama, devido a disponibilidade, viabilidade econômica e equivalência radiodosimétrica ao balão HDR-192Ir, protocolo presente na prática clínica.

5.
Acta cir. bras. ; 28(11): 751-755, Nov. 2013. ilus, tab
Article de Anglais | VETINDEX | ID: vti-9110

RÉSUMÉ

PURPOSE: To describe an experimental model of cutaneous radiation injury in rabbits. METHODS: On this study eight six-month-old New Zealand male rabbits, with an average weight of 2.5kg were used. They were distributed in four groups (n=2 per group). The control group did not receive radiotherapy and the others received one radiotherapy session of 2000, 3000 and 4500 cGy, respectively. Photographic analysis and histopathological evaluation of the irradiated areas were carried out. RESULTS: After 30 days, the animals from the control group had all their hair grown. In spite of that, the animals from group 2000 cGy had a 60-day alopecia and from group 3000 cGy, a 90-day alopecia. After the 30th day, the 3000cGy group demonstrated 90-day cutaneous radiation injuries, graded 3 and 4. One of the animals from group 4500 cGy died on the 7th day with visceral necrosis. The other from the same group had total skin necrosis. A progressive reduction of glands and blood vessels count and an increase on collagen deposition was observed. CONCLUSION: The proposed experimental model is reproductable. This study suggests that the dosage 4500cGy is excessive and the 3000 cGy is the most effective for this experimental model of cutaneous radiation injury in rabbits.(AU)


Sujet(s)
Animaux , Plaies et blessures/métabolisme , Lésions radiques/métabolisme , Dosage , Lapins/classification , Radiothérapie
6.
Acta cir. bras ; Acta cir. bras;28(11): 751-755, Nov. 2013. ilus, tab
Article de Anglais | LILACS, Sec. Est. Saúde SP | ID: lil-695953

RÉSUMÉ

PURPOSE: To describe an experimental model of cutaneous radiation injury in rabbits. METHODS: On this study eight six-month-old New Zealand male rabbits, with an average weight of 2.5kg were used. They were distributed in four groups (n=2 per group). The control group did not receive radiotherapy and the others received one radiotherapy session of 2000, 3000 and 4500 cGy, respectively. Photographic analysis and histopathological evaluation of the irradiated areas were carried out. RESULTS: After 30 days, the animals from the control group had all their hair grown. In spite of that, the animals from group 2000 cGy had a 60-day alopecia and from group 3000 cGy, a 90-day alopecia. After the 30th day, the 3000cGy group demonstrated 90-day cutaneous radiation injuries, graded 3 and 4. One of the animals from group 4500 cGy died on the 7th day with visceral necrosis. The other from the same group had total skin necrosis. A progressive reduction of glands and blood vessels count and an increase on collagen deposition was observed. CONCLUSION: The proposed experimental model is reproductable. This study suggests that the dosage 4500cGy is excessive and the 3000 cGy is the most effective for this experimental model of cutaneous radiation injury in rabbits.


Sujet(s)
Animaux , Mâle , Lapins , Modèles animaux de maladie humaine , Lésions radiques expérimentales , Peau/effets des radiations , Alopécie/étiologie , Nécrose , Dose de rayonnement , Lésions radiques expérimentales/anatomopathologie , Reproductibilité des résultats , Maladies de la peau/étiologie , Maladies de la peau/anatomopathologie , Peau/anatomopathologie , Facteurs temps
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE